RE:RE:RE:RE:RE:RE:RE:Q about BTDrobertshaw wrote: Infinity wrote: I agree with Enrique, we are close to submiting the application for Break through designation. I tried to gather some info from the FDA web page re BTD application process. Appears straightforward. The qualifer would be a significant "UNMET Demand" should exist for this type of cure or treatment. I believe TLT would meet this criteria of unmet demand and the efficacy is already proven, except that we need to wait for a few more patients to cross over from Pending to Partial and Complete recovery.
I for one am going to take a break and sit tight for now and not worry about stock price fluctuations. I expect by Spring 2022 we should be well on our way to be proven winner and may even reach a point by Summer of 2022 that we will no longer be a Penny stock!!. The major move will come when TLT trading volume goes up and gets listed in the TSX instead of the Venture exchange..
Agree with Infiity.
It's in fact the great honor of FDA to grant BTD to us....ASAP ( I amexpecting before Next May).
Otherwise I see no difference betwween FDA and our old friends--Blowjobjoe's bosses.
No other medical treatment technology in human history could ever achieve the height of TLD1433.
It's also "great hornor" of blojobjoe's bosses that almost beated this brilliant technology to death... but, anyway, we survived. So, it's quite safe to say now"Blowjobjoe's bosses ' days are numbered..."